Adverse Events Associated With Bioabsorbable Nasal Implants: A MAUDE Database Analysis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Wiley Country of Publication: England NLM ID: 8508176 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6817 (Electronic) Linking ISSN: 01945998 NLM ISO Abbreviation: Otolaryngol Head Neck Surg Subsets: MEDLINE
    • Publication Information:
      Publication: 2023- : [Oxford] : Wiley
      Original Publication: [Rochester, Minn.] : The Academy, [c1981-
    • Subject Terms:
    • Abstract:
      Bioabsorbable implants (eg, Latera) have recently been approved for addressing nasal valve collapse. The purpose of this study is to summarize adverse events and treatment sequelae associated with bioabsorbable nasal implants queried in the Manufacturer and User Facility Device Experience (MAUDE) database. Of the 26 device reports entered between March 2017 and April 2022, the most frequently reported complications included abscess (n = 13) and implant protrusion (n = 5). Other common symptoms reported greater than 1-year postimplantation included facial pain/discomfort (n = 3) and failure to absorb (n = 3). Management of adverse events included treatment with antibiotics (n = 9), steroid injections (n = 4), and explantation (n = 20). In 3 reports, adverse reactions required a biopsy of adjacent tissue for pathologic analysis. These findings suggest that further research is required to assess the potential long-term complications and optimize the management of bioabsorbable nasal implants. Furthermore, standardized reporting templates may improve the utility of the MAUDE database.
      (© 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation.)
    • References:
      Schuman TA, Senior BA. Treatment paradigm for nasal airway obstruction. Otolaryngol Clin North Am. 2018;51:873-882.
      Clark DW, Del Signore AG, Raithatha R, Senior BA. Nasal airway obstruction: prevalence and anatomic contributors. Ear Nose Throat J. 2018;97:173-176.
      Sidle DM, Stolovitzky P, Ow RA, et al. Twelve-month outcomes of a bioabsorbable implant for in-office treatment of dynamic nasal valve collapse. Laryngoscope. 2020;130:1132-1137.
      Kim DH, Lee HH, Kim SH, Hwang SH. Effectiveness of using a bioabsorbable implant (Latera) to treat nasal valve collapse in patients with nasal obstruction: systemic review and meta-analysis. Int Forum Allergy Rhinol. 2020;10:719-725.
      Nicoló M, Stelter K, Sadick H, Bas M, Berghaus A. Absorbable implant to treat nasal valve collapse. Facial Plast Surg. 2017;33:233-240.
      Stolovitzky P, Senior B, Ow RA, Mehendale N, Bikhazi N, Sidle DM. Assessment of bioabsorbable implant treatment for nasal valve collapse compared to a sham group: a randomized control trial. Int Forum Allergy Rhinol. 2019;9:850-856.
      Stolovitzky P, Sidle DM, Ow RA, Nachlas NE, Most SP. A prospective study for treatment of nasal valve collapse due to lateral wall insufficiency: outcomes using a bioabsorbable implant. Laryngoscope. 2018;128:2483-2489.
      Sidle DM, Stolovitzky P, O'Malley EM, Ow RA, Nachlas NE, Silvers S. Bioabsorbable implant for treatment of nasal valve collapse with or without concomitant procedures. Facial Plast Surg. 2021;37:673-680.
      Rippy MK, Baron S, Rosenthal M, Senior BA. Evaluation of absorbable PLA nasal implants in an ovine model. Laryngoscope Investig Otolaryngol. 2018;3:156-161.
      San Nicoló M, Stelter K, Sadick H, Bas M, Berghaus A. A 2-year follow-up study of an absorbable implant to treat nasal valve collapse. Facial Plast Surg. 2018;34:545-550.
      Singh AK, Kasle DA, Torabi SJ, Manes RP. Adverse events associated with clarifix posterior nasal nerve cryoablation: a MAUDE database analysis. Otolaryngol Head Neck Surg. 2021;165:597-601.
      Narwani V, Torabi SJ, Kasle DA, Patel RA, Lerner MZ, Manes RP. Adverse events associated with corticosteroid-eluting sinus stents: a MAUDE database analysis. Otolaryngol Head Neck Surg. 2022;166:179-182.
      Givissis PK, Stavridis SI, Papagelopoulos PJ, Antonarakos PD, Christodoulou AG. Delayed foreign-body reaction to absorbable implants in metacarpal fracture treatment. Clin Orthop Related Res. 2010;468:3377-3383.
      Sawaya J, Champlain A, Cohen J, Avram M. Barriers to reporting: limitations of the maude database. Dermatol Surg. 2021;47:424-425.
    • Contributed Indexing:
      Keywords: Latera; Manufacturer and User Facility Device Experience; OpenFDA; adverse event; device malfunction; endonasal; nasal airway obstruction; nasal implant; nasal valve
    • Publication Date:
      Date Created: 20230320 Date Completed: 20230424 Latest Revision: 20230428
    • Publication Date:
      20240829
    • Accession Number:
      10.1002/ohn.227
    • Accession Number:
      36939542